<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         dtd-version="1.1"
         xml:lang="en"
         article-type="other">
   <front>
      <journal-meta>
         <journal-id journal-id-type="publisher-id">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="nlm-ta">Zdrav Vestn</journal-id>
         <journal-id journal-id-type="doi">Zdrav Vestn</journal-id>
         <journal-title-group>
            <journal-title>Slovenian Medical Journal</journal-title>
            <trans-title-group xml:lang="sl">
               <trans-title>Zdravniški vestnik</trans-title>
            </trans-title-group>
            <abbrev-journal-title>Zdrav Vestn</abbrev-journal-title>
         </journal-title-group>
         <issn publication-format="ppub" pub-type="ppub">1318-0347</issn>
         <issn publication-format="epub" pub-type="epub">1581-0224</issn>
         <issn-l>0350-0063</issn-l>
         <publisher>
            <publisher-name xml:lang="sl">Slovensko zdravniško društvo</publisher-name>
            <publisher-name xml:lang="en">Slovenian Medical Association</publisher-name>
            <publisher-loc xml:lang="sl">Ljubljana, Slovenia</publisher-loc>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="doi">10.6016/ZdravVestn.2845</article-id>
         <article-id pub-id-type="publisher-id">2845</article-id>
         <article-categories>
            <subj-group subj-group-type="discipline" xml:lang="en">
               <subject>Medicine and health sciences</subject>
               <subj-group>
                  <subject>Oncology</subject>
               </subj-group>
            </subj-group>
            <subj-group subj-group-type="article-type" xml:lang="en">
               <subject>Original scientific article</subject>
            </subj-group>
            <subj-group subj-group-type="heading" xml:lang="en">
               <subject>Oncology</subject>
            </subj-group>
         </article-categories>
         <title-group>
            <article-title xml:lang="en">Oral cancer in Slovenia, 1985–2014</article-title>
            <alt-title alt-title-type="running-head" xml:lang="en">Rak ustnega predela v Sloveniji v letih 1985–2014</alt-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Blatnik</surname>
                  <given-names>Jona</given-names>
               </name>
               <xref ref-type="aff" rid="aff1">1</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Zadnik</surname>
                  <given-names>Vesna</given-names>
               </name>
               <xref ref-type="aff" rid="aff2">2</xref>
            </contrib>
            <contrib contrib-type="author" xlink:type="simple">
               <name name-style="western">
                  <surname>Artnik</surname>
                  <given-names>Barbara</given-names>
               </name>
               <xref ref-type="aff" rid="aff3">3</xref>
               <xref ref-type="corresp" rid="corr"/>
            </contrib>
         </contrib-group>
         <aff id="aff1" xml:lang="en">
            <label>1</label>
            <institution>National Institute of Public Health, Slovenia</institution>
         </aff>
         <aff id="aff2" xml:lang="en">
            <label>2</label>
            <institution>Slovenian Cancer Registry, Institute of Oncology Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <aff id="aff3" xml:lang="en">
            <label>3</label>
            <institution>Chair of Public Health, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</institution>
         </aff>
         <author-notes>
            <fn fn-type="conflict" xml:lang="en">
               <p>The authors have declared that no competing interests exist.</p>
            </fn>
            <fn fn-type="conflict" xml:lang="sl">
               <p>Avtorji so izjavili, da ne obstajajo nobeni konkurenčni interesi.</p>
            </fn>
            <corresp id="corr">Barbara Artnik, e-mail: <email xlink:type="simple"/>
            </corresp>
         </author-notes>
         <pub-date pub-type="ppub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <pub-date pub-type="epub">
            <month>12</month>
            <year>2019</year>
         </pub-date>
         <volume>88</volume>
         <issue>11–12</issue>
         <fpage>493</fpage>
         <lpage>508</lpage>
         <history>
            <date date-type="received">
               <day>11</day>
               <month>6</month>
               <year>2018</year>
            </date>
            <date date-type="accepted">
               <day>9</day>
               <month>7</month>
               <year>2019</year>
            </date>
         </history>
         <permissions>
            <copyright-statement xml:lang="en">Copyright © 2019, Slovenian Medical Association (SZD)</copyright-statement>
            <copyright-statement xml:lang="sl">© 2019, Slovensko zdravniško društvo (SZD)</copyright-statement>
            <copyright-year>2019</copyright-year>
            <copyright-holder xml:lang="en">Slovenian Medical Association (SZD)</copyright-holder>
            <copyright-holder xml:lang="sl">Slovensko zdravniško društvo (SZD)</copyright-holder>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="en">
               <license-p>This is an open access article distributed under the terms of the
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Attribution-NonCommercial
            License</ext-link>, which permits unrestricted use, distribution, and
          reproduction in any medium, provided the original author and source are
          credited and only for non-commercial purposes. </license-p>
            </license>
            <license xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                     xlink:type="simple"
                     xml:lang="sl">
               <license-p>To je članek z odprtim dostopom, ki ga lahko uporabite pod pogoji iz
          <ext-link ext-link-type="uri"
                            xlink:href="https://creativecommons.org/licenses/by-nc/4.0/"
                            xlink:type="simple">Creative Commons Priznanje avtorstva-Nekomercialno
            licence</ext-link>. ki dovoljuje distribucijo, predelavo ali
          prilagoditev, ter gradijo na njem, v nekomercialne namene, z navedbo avtorja
          in izvirnega dela.</license-p>
            </license>
         </permissions>
         <abstract xml:lang="en">
            <title>Abstract</title>
            <p>Background: Oral cancer is a collective name for lip cancer, oral cavity cancer and oropharyngeal cancer; it is one of the most prevalent malignancies in Slovenia. The aim of our study was to analyse the burden of oral cancer in a thirty-year period (1985–2014) in Slovenia.</p>
            <p>Methods: All new cases of oral and pharyngeal cancer (C00–C14) in Slovenia diagnosed between the years 1985–2014 were retrieved from the population based Slovenian Cancer Registry. The analysis of the burden of oral cancer was performed for three primary locations: lip (C00.0–2), oral cavity (C00.3–9, C02.0–3, C02.8–9, C03, C04, C05.0, C05.8–9, C06) and oropharynx (C01, C02.4, C05.1–2, C09, C10). Time trends in the incidence of oral cancer for three primary locations were presented with average annual percent changes in crude incidence rates.</p>
            <p>Results: 9,442 new cases of oral and pharyngeal cancer were observed between 1985 and 2014. Final analysis was performed for 7,190 new cases of lip, oral cavity and oropharyngeal cancer; 83.4 % of patients were men and 16.6 % were women. Average age of a patient at diagnosis was 59.8 years ± 11.3. The highest incidence of lip cancer was observed in 80+ age group, and the highest incidence of oral and oropharyngeal cancer was observed in 55–59 age group. The proportion of male patients was higher in all three cancer groups. The majority of new cases of lip cancer were diagnosed at a localised stage, whereas the majority of new cases of oral and oropharyngeal cancer were diagnosed at a regional stage. Survival rates were highest for patients with lip cancer and lowest for patients with oropharyngeal cancer. A thirty-year time trend showed that the incidence of lip cancer was decreasing, whereas the incidence rates of oral cavity cancer and oropharyngeal cancer were increasing.</p>
            <p>Conclusion: Oral cancer is one of the biggest public health and socioeconomic problems of modern society. Early detection of oral cancer improves survival rates and the quality of life of patients. It is necessary to pay attention to the burden of this disease and manage its prevention and control.</p>
         </abstract>
         <kwd-group xml:lang="en">
            <kwd>rak ustnega predela</kwd>
            <kwd>breme raka</kwd>
            <kwd>incidenca</kwd>
            <kwd>časovni trend</kwd>
            <kwd>javno zdravje</kwd>
         </kwd-group>
      </article-meta>
   </front>
   <body>
      <sec id="s1" sec-type="Introduction">
         <label>1</label>
         <title>Introduction</title>
         <p>Oral cancer is a collective name for lip cancer, oral cavity cancer and oropharyngeal cancer. It is ranked 6<sup>th</sup> among all cancer cases in the world. The annual incidence is around 400,000 cases and varies widely across the globe (<xref ref-type="bibr" rid="b1">1</xref>). The highest incidence of oral cancer is in Sri Lanka, India, Pakistan, Bangladesh, Hungary, and France (<xref ref-type="bibr" rid="b2">2</xref>).</p>
         <p>The major etiologic factors responsible for up to 90 % of cases are tobacco and alcohol use. Other cancer-related factors include human papillomavirus (HPV) infection, marijuana smoking, low-fruit and vegetable consumption diets, poor oral hygiene, social inequality, exposure to hazardous chemicals in the workplace, chronic trauma to the oral mucosa, UV radiation, immunosuppression (<xref ref-type="bibr" rid="b3">3</xref>-<xref ref-type="bibr" rid="b5">5</xref>). In the recent years, researchers have paid increasing attention to the role of HPV infection, having identified a high proportion of HPV-positive cases of oral cancer (16.2 % in Europe) (<xref ref-type="bibr" rid="b6">6</xref>). The infection is associated with early first sexual intercourse, a greater number of sexual partners, oral sexual practices, and same-sex practices (<xref ref-type="bibr" rid="b7">7</xref>-<xref ref-type="bibr" rid="b9">9</xref>).</p>
         <p>Oral cancer is more commonly reported in men over 50, although changes in smoking and drinking habits have led to an increase in cancer among women. In 1950, the ratio of males to females was 6:1, whereas today it is 2:1 (<xref ref-type="bibr" rid="b4">4</xref>). Due to HPV infections, the incidence in the developed world is rising among young adults, especially men with higher socioeconomic status, with no other risk factors for cancer or only a minor factor (<xref ref-type="bibr" rid="b10">10</xref>-<xref ref-type="bibr" rid="b12">12</xref>). A typical cancerous lesion in an ulcer, which most commonly occurs on the tongue, floor of the mouth and cheeks. Up to 70 % of cancers arise from a precancerous lesion (<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b13">13</xref>). Histologically, 95 % are squamous cell carcinomas (<xref ref-type="bibr" rid="b14">14</xref>,<xref ref-type="bibr" rid="b15">15</xref>). Although early diagnosis is relatively straightforward, most cases of oral cancer are detected in the advanced stage. The average 5-year survival rate is only about 50 %. Survival has remained virtually unchanged in recent decades despite advances in diagnosis and treatment (<xref ref-type="bibr" rid="b4">4</xref>). A review article by Lafaurie et al. summarizes that HPV-positive cases of oral cancer have better outcomes than HPV-negative cases of oral cancer (<xref ref-type="bibr" rid="b16">16</xref>). A systematic examination and meta-analysis of oropharyngeal cancer by O’Rorke et al. found a 52 % lower risk of disease progression, 63 % lower risk of disease recurrence, and 53 % reduced mortality (<xref ref-type="bibr" rid="b17">17</xref>). Their findings are also supported by Strojan et al.’s study conducted between 2007 and 2008 on histopathological specimens of patients with oropharyngeal cancer in Slovenia; HPV infection is an independent determinant of a reduced risk of oropharyngeal cancer progression and reduced mortality (<xref ref-type="bibr" rid="b11">11</xref>).</p>
         <p>Oral cancer is one of the most common malignancies also in Slovenia, accounting for 54 % of cases of head and neck cancer that is ranked 5<sup>th</sup> for men, 14<sup>th</sup> for women, and 8<sup>th</sup> for overall cancer incidence (<xref ref-type="bibr" rid="b18">18</xref>).</p>
         <p>The purpose of our study was to present the burden of oral cancer over a thirty-year period (1985–2014) in Slovenia. Basic epidemiological indicators were studied: incidence and time trend with respect to each cancer site, gender and age of patients, stage at diagnosis, and especially the observed survival of patients over a 10-year period (2005–2014).</p>
         <table-wrap position="anchor" id="table1">
            <label>Table 1:</label>
            <caption>
               <p> Oral cancer burden, 1985−2014.</p>
            </caption>
            <table>
               <colgroup>
                  <col/>
                  <col/>
                  <col/>
                  <col/>
               </colgroup>
               <thead>
                  <tr>
                     <th>Cancer site</th>
                     <th>ICD-10</th>
                     <th>Incidence (N)</th>
                     <th>Proportion regarding cancer site (%)</th>
                  </tr>
               </thead>
               <tbody>
                  <tr>
                     <td rowspan="4">Lip</td>
                     <td>C00.1 – external lower lip</td>
                     <td>697</td>
                     <td>90.0</td>
                  </tr>
                  <tr>
                     <td>C00.0 – external upper lip</td>
                     <td>71</td>
                     <td>9.2</td>
                  </tr>
                  <tr>
                     <td>C00.2 – external lip, unspecified</td>
                     <td>6</td>
                     <td>0.8</td>
                  </tr>
                  <tr>
                     <th content-type="table-subhead">SUM</th>
                     <th content-type="table-subhead">774</th>
                     <th content-type="table-subhead">100.0</th>
                  </tr>
                  <tr>
                     <td rowspan="28">Oral cavity</td>
                     <td>C04.9 – floor of mouth, unspecified</td>
                     <td>667</td>
                     <td>23.2</td>
                  </tr>
                  <tr>
                     <td>C02.1 – border of tongue</td>
                     <td>446</td>
                     <td>15.5</td>
                  </tr>
                  <tr>
                     <td>C06.2 – retromolar area</td>
                     <td>190</td>
                     <td>6.6</td>
                  </tr>
                  <tr>
                     <td>C04.1 – lateral floor of mouth</td>
                     <td>174</td>
                     <td>6.0</td>
                  </tr>
                  <tr>
                     <td>C02.9 – tongue, unspecified</td>
                     <td>169</td>
                     <td>5.9</td>
                  </tr>
                  <tr>
                     <td>C02.3 – anterior two-thirds of tongue, part unspecified</td>
                     <td>153</td>
                     <td>5.3</td>
                  </tr>
                  <tr>
                     <td>C04.8 – overlapping lesion of floor of mouth</td>
                     <td>149</td>
                     <td>5.2</td>
                  </tr>
                  <tr>
                     <td>C06.9 – mouth, unspecified</td>
                     <td>140</td>
                     <td>4.9</td>
                  </tr>
                  <tr>
                     <td>C03.1 – lower gum</td>
                     <td>132</td>
                     <td>4.6</td>
                  </tr>
                  <tr>
                     <td>C04.0 – anterior floor of mouth</td>
                     <td>115</td>
                     <td>4.0</td>
                  </tr>
                  <tr>
                     <td>C03.0 – upper gum</td>
                     <td>86</td>
                     <td>3.0</td>
                  </tr>
                  <tr>
                     <td>C06.0 – cheek mucosa</td>
                     <td>86</td>
                     <td>3.0</td>
                  </tr>
                  <tr>
                     <td>C02.8 – overlapping lesion of tongue</td>
                     <td>72</td>
                     <td>2.5</td>
                  </tr>
                  <tr>
                     <td>C05.8 – overlapping lesion of palate</td>
                     <td>59</td>
                     <td>2.0</td>
                  </tr>
                  <tr>
                     <td>C05.0 – hard palate</td>
                     <td>54</td>
                     <td>1.9</td>
                  </tr>
                  <tr>
                     <td>C00.9 – lip, unspecified</td>
                     <td>37</td>
                     <td>1.3</td>
                  </tr>
                  <tr>
                     <td>C06.1 – vestibule of mouth</td>
                     <td>36</td>
                     <td>1.3</td>
                  </tr>
                  <tr>
                     <td>C02.2 – ventral surface of tongue</td>
                     <td>23</td>
                     <td>0.8</td>
                  </tr>
                  <tr>
                     <td>C00.4 – lower lip, inner aspect</td>
                     <td>19</td>
                     <td>0.7</td>
                  </tr>
                  <tr>
                     <td>C05.9 – palate, unspecified</td>
                     <td>18</td>
                     <td>0.6</td>
                  </tr>
                  <tr>
                     <td>C02.0 – dorsal surface of tongue</td>
                     <td>15</td>
                     <td>0.5</td>
                  </tr>
                  <tr>
                     <td>C06.8 – overlapping lesion of other and unspecified parts of mouth</td>
                     <td>14</td>
                     <td>0.5</td>
                  </tr>
                  <tr>
                     <td>C03.9 – gum, unspecified</td>
                     <td>8</td>
                     <td>0.3</td>
                  </tr>
                  <tr>
                     <td>C00.5 – lip, unspecified, inner aspect</td>
                     <td>3</td>
                     <td>0.1</td>
                  </tr>
                  <tr>
                     <td>C00.6 – commissure of lip</td>
                     <td>3</td>
                     <td>0.1</td>
                  </tr>
                  <tr>
                     <td>C00.3 – upper lip, inner aspect</td>
                     <td>3</td>
                     <td>0.1</td>
                  </tr>
                  <tr>
                     <td>C00.8 – overlapping lesion of lip</td>
                     <td>2</td>
                     <td>0.1</td>
                  </tr>
                  <tr>
                     <th content-type="table-subhead">SUM</th>
                     <th content-type="table-subhead">2873</th>
                     <th content-type="table-subhead">100.0</th>
                  </tr>
                  <tr>
                     <td rowspan="16">Oropharynx</td>
                     <td>C10.9 – oropharynx, unspecified</td>
                     <td>902</td>
                     <td>25.5</td>
                  </tr>
                  <tr>
                     <td>C01 – base of tongue</td>
                     <td>505</td>
                     <td>14.2</td>
                  </tr>
                  <tr>
                     <td>C09.9 – tonsil, unspecified</td>
                     <td>462</td>
                     <td>13.0</td>
                  </tr>
                  <tr>
                     <td>C10.8 – overlapping lesion of oropharynx</td>
                     <td>424</td>
                     <td>12.0</td>
                  </tr>
                  <tr>
                     <td>C09.0 – tonsillar fossa</td>
                     <td>284</td>
                     <td>8.0</td>
                  </tr>
                  <tr>
                     <td>C05.1 – soft palate</td>
                     <td>197</td>
                     <td>5.6</td>
                  </tr>
                  <tr>
                     <td>C10.0 – vallecula</td>
                     <td>148</td>
                     <td>4.2</td>
                  </tr>
                  <tr>
                     <td>C10.2 – lateral wall of oropharynx</td>
                     <td>147</td>
                     <td>4.1</td>
                  </tr>
                  <tr>
                     <td>C09.1 – tonsillar pillar (anterior)(posterior)</td>
                     <td>136</td>
                     <td>3.8</td>
                  </tr>
                  <tr>
                     <td>C05.2 – uvula</td>
                     <td>119</td>
                     <td>3.4</td>
                  </tr>
                  <tr>
                     <td>C09.8 – overlapping lesion of tonsil</td>
                     <td>84</td>
                     <td>2.4</td>
                  </tr>
                  <tr>
                     <td>C10.3 – posterior wall of oropharynx</td>
                     <td>82</td>
                     <td>2.3</td>
                  </tr>
                  <tr>
                     <td>C10.1 – anterior surface of epiglottis</td>
                     <td>46</td>
                     <td>1.3</td>
                  </tr>
                  <tr>
                     <td>C02.4 – lingual tonsil</td>
                     <td>6</td>
                     <td>0.2</td>
                  </tr>
                  <tr>
                     <td>C10.4 – branchial cleft</td>
                     <td>1</td>
                     <td>0.0</td>
                  </tr>
                  <tr>
                     <td>SUM</td>
                     <td>3543</td>
                     <td>100.0</td>
                  </tr>
                  <tr>
                     <td>Sum</td>
                     <th content-type="table-subhead"/>
                     <th content-type="table-subhead">7190</th>
                     <th content-type="table-subhead"/>
                  </tr>
               </tbody>
            </table>
         </table-wrap>
      </sec>
      <sec id="s2" sec-type="Methods">
         <label>2</label>
         <title>Methods</title>
         <sec id="s2.1" sec-type="Data sources, subjects, and inclusion criteria">
            <label>2.1</label>
            <title>Data sources, subjects, and inclusion criteria</title>
            <p>We obtained data on all cases of oral and pharyngeal cancer in the period from 1985 to 2014 from the database of the Cancer Registry of the Republic of Slovenia (CRS) (cases of head and neck cancer without cases of throat, nasal cavity and paranasal sinuses, and middle ear malignancies). The site of malignancy is defined in the CRS by the tenth revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). Our analysis incorporated all cases registered with ICD-10 codes between C00 and C14. We obtained anonymized information about:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>patient gender and age;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>date of diagnosis;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>hospital where they were diagnosed;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>site and morphology;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>cancer stage;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>vital status and date of death of the deceased;</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>healthcare region, statistical region, and the administrative unit of the place of residence.</p>
               </list-item>
            </list>
            <p>The analysis excluded all subjects that were reported to the CRS with the following primary sites C07, C08, C11, C12, C13, C14; the exclusion is explained in the discussion section of this article.</p>
            <p>Data on the number and age structure of the population in this period were obtained from the data portal of the Statistical Office of the Republic of Slovenia.</p>
         </sec>
         <sec id="s2.2" sec-type="Defining oral cancer">
            <label>2.2</label>
            <title>Defining oral cancer</title>
            <p>The classification of oral cancer is not clearly defined in the literature. This problem is further addressed in the discussion section of this article. For defining oral cancer in our analysis we used ICD-10 and the eighth edition of the TNM Classification of Malignant Tumors of the Union for International Cancer Control (UICC) (<xref ref-type="bibr" rid="b19">19</xref>). The primary sites of the oropharyngeal region (C00 – C14) were classified into the following groups:</p>
            <list>
               <list-item>
                  <label>•</label>
                  <p>lip (C00.0–2);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>oral cavity (C00.3–9, C02.0–3 and C02.8–9,C03, C04, C05.0 and C05.8–9, C06);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>oropharynx (C01, C02.4, C05.1–2, C09, C10);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>salivary glands (C07, C08);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>nasopharynx (C11);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>pyriform sinus (C12);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>hypopharynx (C13);</p>
               </list-item>
               <list-item>
                  <label>•</label>
                  <p>other (C14).</p>
               </list-item>
            </list>
            <p>The analysis was prepared for three basic primary sites: the lip, oral cavity, and oropharynx. The classification of individual anatomical cancer sites by ICD-10 of the three sites is presented in <xref ref-type="table" rid="table1">Table 1</xref>.</p>
         </sec>
         <sec id="s2.3" sec-type="Data analysis">
            <label>2.3</label>
            <title>Data analysis</title>
            <p>For the entire thirty-year period (1985–2014), we reported the incidence and proportions of oral cancer by individual site, gender, patient age, and stage of cancer at diagnosis. We also estimated the thirty-year incidence trend by site. We have prepared a more detailed presentation for the last ten-year period (2005–2014). We provide the incidence, the proportion of all cancer cases, cumulative risk, gross incidence rate, age-standardized rate, and estimated percentages of annual gross and age-standardized incidence rates for each site. The observed patient survival by site is also added.</p>
            <p>Data were analysed using the <italic>Microsoft Excel 2016</italic> and <italic>IBM SPSS Statistics for Windows software</italic> (version 24.0) (<xref ref-type="bibr" rid="b20">20</xref>). We used the direct standardization method and the world standard population for the age standardization of incidence rates. The time trends of the number of new cancer cases by site were analysed using the <italic>Joinpoint Regression Program</italic> (version 4.1.1; Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute, October 2014) (<xref ref-type="bibr" rid="b21">21</xref>). The trends are thus presented in the form of an average annual percent change (AAPC) of a gross incidence rate. The 95 % confidence interval values were also calculated for each AAPC. The limit of statistical significance of the trends was set at p &lt; 0.05.</p>
            <table-wrap position="anchor" id="table2">
               <label>Table 2:</label>
               <caption>
                  <p> Incidence and risk of oral cancer occurrence, 2005−2014.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                  </colgroup>
                  <tbody>
                     <tr>
                        <th rowspan="2">Incidence (average 2005–2014)</th>
                        <th colspan="3">Lip</th>
                        <th colspan="3">Oral cavity</th>
                        <th colspan="3">Oropharynx</th>
                     </tr>
                     <tr>
                        <th>Men</th>
                        <th>Women</th>
                        <th>Both sexes</th>
                        <th>Men</th>
                        <th>Women</th>
                        <th>Both sexes</th>
                        <th>Men</th>
                        <th>Women</th>
                        <th>Both sexes</th>
                     </tr>
                     <tr>
                        <td>Number of new cases per year</td>
                        <td align="right">16</td>
                        <td align="right">7</td>
                        <td align="right">23</td>
                        <td align="right">73</td>
                        <td align="right">28</td>
                        <td align="right">101</td>
                        <td align="right">109</td>
                        <td align="right">19</td>
                        <td align="right">128</td>
                     </tr>
                     <tr>
                        <td>Percentage of all cancers (%)</td>
                        <td align="right">0.2</td>
                        <td align="right">0.1</td>
                        <td align="right">0.2</td>
                        <td align="right">1.06</td>
                        <td align="right">0.48</td>
                        <td align="right">0.79</td>
                        <td align="right">1.6</td>
                        <td align="right">0.3</td>
                        <td align="right">1.0</td>
                     </tr>
                     <tr>
                        <td>Percentage of all cancers except non-melanoma skin (%)</td>
                        <td align="right">0.3</td>
                        <td align="right">0.1</td>
                        <td align="right">0.2</td>
                        <td align="right">1.25</td>
                        <td align="right">0.58</td>
                        <td align="right">0.95</td>
                        <td align="right">1.9</td>
                        <td align="right">0.4</td>
                        <td align="right">2.2</td>
                     </tr>
                     <tr>
                        <td>Risk of cancer occurrencebefore age 75 (CR) (%)</td>
                        <td align="right">0.10</td>
                        <td align="right">0.02</td>
                        <td align="right">0.06</td>
                        <td align="right">0.54</td>
                        <td align="right">0.17</td>
                        <td align="right">0.35</td>
                        <td align="right">0.81</td>
                        <td align="right">0.13</td>
                        <td align="right">0.46</td>
                     </tr>
                     <tr>
                        <td>Crude incidence rate per 100,000</td>
                        <td align="right">1.6</td>
                        <td align="right">0.8</td>
                        <td align="right">1.1</td>
                        <td align="right">7.3</td>
                        <td align="right">2.7</td>
                        <td align="right">4.9</td>
                        <td align="right">10.9</td>
                        <td align="right">1.9</td>
                        <td align="right">6.3</td>
                     </tr>
                     <tr>
                        <td>Age-standardised incidence rate (ARS) per 100,000 (W)</td>
                        <td align="right">0.9</td>
                        <td align="right">0.2</td>
                        <td align="right">0.5</td>
                        <td align="right">4.5</td>
                        <td align="right">1.5</td>
                        <td align="right">3.0</td>
                        <td align="right">6.8</td>
                        <td align="right">1.1</td>
                        <td align="right">3.8</td>
                     </tr>
                     <tr>
                        <td>Estimated annual change of crude incidence rate latest 10 years (%)</td>
                        <td align="right">-2.5</td>
                        <td align="right">-12.5</td>
                        <td align="right">-5.2</td>
                        <td align="right">-0.9</td>
                        <td align="right">0.3</td>
                        <td align="right">-0.6</td>
                        <td align="right">1.7</td>
                        <td align="right">0.3</td>
                        <td align="right">2.0</td>
                     </tr>
                     <tr>
                        <td>Estimated annual change of ASR over the past 10 years (%)</td>
                        <td align="right">-4.6</td>
                        <td align="right">-16.5</td>
                        <td align="right">-7.0</td>
                        <td align="right">-2.0</td>
                        <td align="right">-1.8</td>
                        <td align="right">-1.9</td>
                        <td align="right">-0.9</td>
                        <td align="right">2.9</td>
                        <td align="right">0.6</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
         </sec>
      </sec>
      <sec id="s3" sec-type="Results">
         <label>3</label>
         <title>Results</title>
         <p>We obtained data for all oral and pharyngeal cancer cases (C00 – C14; N = 9,442; N - number of new cancer cases) for the 1985–2014 period. All cases of oral cancer (C00 – C06, C09 and C10; N = 7,190) were included in the final analysis. The difference in the number of cancer cases (N = 2.252) represents those cases of oral and pharyngeal cancer that were excluded from the analysis (C07, C08, C11 – C14).</p>
         <p>The incidences and proportions by site are shown in <xref ref-type="table" rid="table1">Table 1</xref>. There were 5,994 (83.4 %) men and 1,197 (16.6 %) women among the subjects. The average age of the subjects at diagnosis was 59.8 years ± 11.3; in males 58.9 years ± 10.5 and in females 64.0 years ± 14.1.</p>
         <sec id="s3.1"
              sec-type="Incidence and survival of patients with oral cancer">
            <label>3.1</label>
            <title>Incidence and survival of patients with oral cancer</title>
            <p>
               <xref ref-type="table" rid="table2">Table 2</xref> presents basic epidemiological data on oral cancer. Similar cancer fact sheets (CFS) are also displayed at SLORA’s online portal (<xref ref-type="bibr" rid="b18">18</xref>). In the last decade, the number of new cases of oral cavity cancer in men was almost three times the number of new cases in women, and the number of new cases of oropharyngeal cancer in men was almost six times the number of new cases in women. Oral cavity cancer accounts for less than one percent of all cancers (with and without non-melanoma skin cancer), and oropharyngeal cancer accounts for a good two percent of all cancers (with and without non-melanoma skin cancer). Men born in Slovenia in 2014 are five times more likely to develop lip cancer by the age of 75 than women; the risk of oral cavity cancer is almost three times higher as in women; the risk of developing oropharyngeal cancer is six times higher as in women.</p>
            <p>The distribution of patients by age at diagnosis is similar for oral cavity and oropharyngeal cancer, whereas the age structure of patients with lip cancer is different (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
            <fig position="anchor" id="fig1">
               <label>Figure 1:</label>
               <caption>
                  <p> New cases of oral cancer by cancer site and patient age at diagnosis, 1985−2014.</p>
               </caption>
               <p>
                  <graphic xlink:href="2845-en-web-resources/image/zdravvestn-2845-en-01.png"/>
               </p>
            </fig>
            <p>Most cases of lip cancer are in the 80 + age group, and most cases of oral cavity and oropharyngeal cancer are in the 55–59 age group. There were 19 cases of oral cavity cancer before the age of 30, and no cases of oral cavity or oropharyngeal cancer before that age were reported. The youngest patient with oral cavity cancer was 19 years old.</p>
            <p>In all three cancer groups the proportion of men is higher than the proportion of women. Most cases of lip cancer are detected in the localised stage, and most cases of oral cavity and oropharyngeal cancers in the regional stage. The survival of patients is the highest in those with lip cancer, and the lowest in patients with oropharyngeal cancer. Over the last 10 years, the average 1-/3-/5-year survival of patients with oropharyngeal cancer has not significantly improved compared to the 1985–2014 period and still remains low (<xref ref-type="table" rid="table3">Table 3</xref>).</p>
         </sec>
         <sec id="s3.2"
              sec-type="Time trend of lip, oral cavity, and oropharyngeal cancer in the years 1985–2014">
            <label>3.2</label>
            <title>Time trend of lip, oral cavity, and oropharyngeal cancer in the years 1985–2014</title>
            <p>The thirty-year time trend of oral cancer shows a decrease in the number of cases of lip cancer, but in contrast, the number of cases of oral cavity and oropharyngeal cancer is increasing (<xref ref-type="fig" rid="fig2">Figure 2</xref>). There were no sudden changes in the incidence increase or decrease during this period.</p>
            <fig position="anchor" id="fig2">
               <label>Figure 2:</label>
               <caption>
                  <p> Time trend of oral cancer by cancer site, 1985−2014.</p>
               </caption>
               <p>
                  <graphic xlink:href="2845-en-web-resources/image/zdravvestn-2845-en-02.png"/>
               </p>
               <p>* AAPC – average annual percent change of crude incidence rate, 1985–2014.</p>
            </fig>
         </sec>
      </sec>
      <sec id="s4" sec-type="Discussion">
         <label>4</label>
         <title>Discussion</title>
         <sec id="s4.1" sec-type="Burden of oral cancer">
            <label>4.1</label>
            <title>Burden of oral cancer</title>
            <p>The results of our research showed that the number of new oral cancer cases in Slovenia by individual site is as expected. Most lip cancer cases are in the 80 + age group. This is due to the long-term effects of solar radiation and the associated effects of other risk factors (<xref ref-type="bibr" rid="b22">22</xref>). Lip cancer most often occurs on the external lower lip, which is exposed to sunlight, the effects of alcohol, and hot smoke when smoking tobacco more than the upper lip. Immunosuppressant therapy is also an important risk factor (<xref ref-type="bibr" rid="b23">23</xref>). On average, younger people are more affected by oral cavity and oropharyngeal cancer, since tobacco and alcohol use, which are the most common etiological factors (<xref ref-type="bibr" rid="b4">4</xref>), have a synergistic and multiplicative risk effect (<xref ref-type="bibr" rid="b3">3</xref>).</p>
            <p>In 2007, the International Agency for Research on Cancer (IARC) included HPV as a group of carcinogenic agents (<xref ref-type="bibr" rid="b24">24</xref>). The association between HPV infection and oropharyngeal cancer has been demonstrated (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>), so recently a growing influence on developing oropharyngeal cancer in the younger population has been attributed to an HPV infection (<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b27">27</xref>). The population attributable fraction (PAF) is calculated based on the frequency of the infection in the cancer tissue and the relative risk of infection (<xref ref-type="bibr" rid="b28">28</xref>). This signifies the number of new cancer cases that could be prevented if the HPV infection was avoided or if the HPV infection was successfully treated. Oral cavity and oropharyngeal cancers attributable to HPV infection account for 4.3 % and 30.8 %, respectively (<xref ref-type="bibr" rid="b29">29</xref>,<xref ref-type="bibr" rid="b30">30</xref>). In our study we show, like Haeggblom et al. in their systematic review of the literature on the prevalence of HPV in oropharyngeal cancer (<xref ref-type="bibr" rid="b31">31</xref>) that more new cases of oropharyngeal cancer occur in the lymphoepithelial tissue (base of the tongue, C01; tonsils, C09) than other sites of the oropharynx. Haeggblom et al. have found HPV more frequently in lymphoepithelial tissue than in non-lymphoepithelial tissue of the oropharynx (<xref ref-type="bibr" rid="b31">31</xref>). The influence of risk factors on the development of oral cancer can only be inferred from the data we used in the study, but we cannot determine their correlation. CRS does not record data on smoking status, alcohol consumption, and HPV status of patients (<xref ref-type="bibr" rid="b11">11</xref>).</p>
            <table-wrap position="anchor" id="table3">
               <label>Table 3:</label>
               <caption>
                  <p> New cases of oral cancer by patient sex and cancer stage, 1985−2014, and observed survival, 2005−2014.</p>
               </caption>
               <table>
                  <colgroup>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                     <col/>
                  </colgroup>
                  <tbody>
                     <tr>
                        <th rowspan="2" colspan="2">
                           <p>Cancer site</p>
                           <p>N</p>
                        </th>
                        <th align="center" colspan="2">Lip</th>
                        <th align="center" colspan="2">Oral cavity</th>
                        <th align="center" colspan="2">Oropharynx</th>
                     </tr>
                     <tr>
                        <th align="center">%</th>
                        <th align="center">N</th>
                        <th align="center">%</th>
                        <th align="center">N</th>
                        <th align="center">%</th>
                        <th/>
                     </tr>
                     <tr>
                        <td rowspan="2">Sex</td>
                        <td>M</td>
                        <td align="right">574</td>
                        <td align="right">74.2</td>
                        <td align="right">2291</td>
                        <td align="right">79.7</td>
                        <td align="right">3129</td>
                        <td align="right">88.3</td>
                     </tr>
                     <tr>
                        <td>W</td>
                        <td align="right">200</td>
                        <td align="right">25.8</td>
                        <td align="right">582</td>
                        <td align="right">20.3</td>
                        <td align="right">414</td>
                        <td align="right">11.7</td>
                     </tr>
                     <tr>
                        <td rowspan="4">Stage</td>
                        <td>localised</td>
                        <td align="right">708</td>
                        <td align="right">91.5</td>
                        <td align="right">991</td>
                        <td align="right">34.5</td>
                        <td align="right">541</td>
                        <td align="right">15.3</td>
                     </tr>
                     <tr>
                        <td>regional</td>
                        <td align="right">54</td>
                        <td align="right">7.0</td>
                        <td align="right">1783</td>
                        <td align="right">62.1</td>
                        <td align="right">2857</td>
                        <td align="right">80.6</td>
                     </tr>
                     <tr>
                        <td>remote</td>
                        <td align="right">1</td>
                        <td align="right">0.1</td>
                        <td align="right">46</td>
                        <td align="right">1.6</td>
                        <td align="right">104</td>
                        <td align="right">2.9</td>
                     </tr>
                     <tr>
                        <td>no available data</td>
                        <td align="right">11</td>
                        <td align="right">1.4</td>
                        <td align="right">53</td>
                        <td align="right">1.8</td>
                        <td align="right">41</td>
                        <td align="right">1.2</td>
                     </tr>
                     <tr>
                        <td rowspan="4">Observed survival</td>
                        <td>1-year</td>
                        <td align="right">/</td>
                        <td align="right">94</td>
                        <td align="right">/</td>
                        <td align="right">78</td>
                        <td align="right">/</td>
                        <td align="right">68</td>
                     </tr>
                     <tr>
                        <td>3-year</td>
                        <td align="right">/</td>
                        <td align="right">79</td>
                        <td align="right">/</td>
                        <td align="right">55</td>
                        <td align="right">/</td>
                        <td align="right">46</td>
                     </tr>
                     <tr>
                        <td>5-year</td>
                        <td align="right">/</td>
                        <td align="right">70</td>
                        <td align="right">/</td>
                        <td align="right">45</td>
                        <td align="right">/</td>
                        <td align="right">37</td>
                     </tr>
                     <tr>
                        <td>10-year</td>
                        <td align="right">/</td>
                        <td align="right">43</td>
                        <td align="right">/</td>
                        <td align="right">33</td>
                        <td align="right">/</td>
                        <td align="right">25</td>
                     </tr>
                  </tbody>
               </table>
            </table-wrap>
            <p>When observing gender based disease prevalence, the results of our study show that men are more likely to develop oral cancer. Lip cancer occurs three times more often, oral cavity cancer four times more often, and oropharyngeal cancer seven times more often than in women. The highest proportion of localised stage of the disease is found in lip cancer, whereas oral cavity and oropharyngeal cancer is dominated by a higher proportion of regional stage of the disease, which is associated with poorer survival of patients. There are several reasons for this. The accessibility of individual oral sites for clinical examination and self-examination varies from person to person. Irregular visits to the dentist can also contribute to cancer development, as well as inaccurate and irregular examinations of the oral area when visiting a selected dentist or physician.</p>
            <p>Over the last decade, the gross incidence rate and age-standardized rate of oral cancer have been declining, except for oral cavity cancer in women and oropharyngeal cancer in both sexes where they are on the rise.</p>
            <p>When reporting the incidence of oral cancer, we considered the calculation with and without non-melanoma skin cancer. It has been suggested that in Slovenia – as well as in other European population cancer registries – the registration of non-melanoma skin cancer and those malignancies treated in outpatient settings is less detailed (<xref ref-type="bibr" rid="b32">32</xref>). In Slovenia, non-melanoma skin cancer accounted for 18 % of all new cancer cases in 2014 (<xref ref-type="bibr" rid="b33">33</xref>). In some countries, cancer registries do not have access to outpatient (and treated) non-melanoma skin cancer cases, therefore, they are not registered. This is the reason why non-melanoma skin cancer is excluded from international comparisons (<xref ref-type="bibr" rid="b34">34</xref>).</p>
         </sec>
         <sec id="s4.2" sec-type="Time trend of oral cancer">
            <label>4.2</label>
            <title>Time trend of oral cancer</title>
            <p>Our time trend analysis aimed at presenting the longest possible timeframe. CRS holds data on incidence and prevalence from 1950 onwards, and mortality and survival rates from 1985 onwards. Year 1985 thus served as the beginning of our thirty-year analysis (<xref ref-type="bibr" rid="b35">35</xref>).</p>
            <p>The number of new cases of lip cancer is declining. This is a reflection of the successful awareness of the harmful effects of solar radiation and UV protection (<xref ref-type="bibr" rid="b36">36</xref>,<xref ref-type="bibr" rid="b37">37</xref>), and also tobacco and alcohol policy measures (<xref ref-type="bibr" rid="b38">38</xref>,<xref ref-type="bibr" rid="b39">39</xref>). Nevertheless, prevention in this area needs to be strengthened. In contrast, the number of new cases of oral cavity and oropharyngeal cancer is increasing. Recommendations and awareness-raising on the harmful effects of alcohol and tobacco smoking in reducing incidence are not sufficient on their own. The changing trends in the incidence of oral cavity and oropharyngeal cancer in the Slovenian population are probably due to changes in exposure to risk factors in recent decades (<xref ref-type="bibr" rid="b11">11</xref>). The proportion of smokers has declined from 36 % (<xref ref-type="bibr" rid="b40">40</xref>) since 1978 to 22.6 % in 2012 (it has been decreasing in male smokers and has been stagnant in women since 2001) (<xref ref-type="bibr" rid="b41">41</xref>). Drinking excessive amounts of alcohol is declining but remains above the EU average, with increasing high-risk intoxication several times a year and from 1 to 3 times a month (<xref ref-type="bibr" rid="b42">42</xref>,<xref ref-type="bibr" rid="b43">43</xref>). The increasing incidence of oropharyngeal cancer is largely attributed to an HPV infection (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>). The proportion of people consuming fruits and vegetables, who have cancer-protective effects, is also declining (<xref ref-type="bibr" rid="b44">44</xref>,<xref ref-type="bibr" rid="b45">45</xref>).</p>
            <p>A direct comparison of the trend observed in our study to other studies is not possible, as these studies track multi-year cancer trends for the entire oral and pharyngeal region (C00 – C14). According to EUCAN 2012 data, the incidence in Slovenia was 12.6/100,000 inhabitants. In Northern Europe the incidence is highest in Denmark (13.0/100,000 inhabitants), in Western Europe in France (15.0/100,000 inhabitants), in Southern Europe in Portugal (15.4/100,000 inhabitants), in Eastern Europe in Hungary (23.3/100,000 inhabitants). Hungary also has the highest incidence in Europe, almost nine times the incidence in Cyprus, where it is the lowest (2.7/100,000 inhabitants) (<xref ref-type="bibr" rid="b27">27</xref>). Great Britain sees an increase in the burden of oral cavity cancer, in south-east England between 1987 and 2006 especially tongue and tongue base, gum and palate cancers (<xref ref-type="bibr" rid="b46">46</xref>). In the Netherlands, the incidence of oral cavity cancer increased from 1991 to 2010, as did mortality, and patient survival improved. The incidence of oral cavity cancer has replaced laryngeal cancer as the most frequently occurring cancer in the head and neck area in the Netherlands (<xref ref-type="bibr" rid="b47">47</xref>). In Denmark, the incidence of oral cavity and oropharyngeal cancer increased between 1980 and 2012 (<xref ref-type="bibr" rid="b48">48</xref>). The United States saw a decrease in incidence and mortality, but an increase in both within certain demographic groups in the years 1975–2004 (<xref ref-type="bibr" rid="b49">49</xref>). An increase in the incidence of oropharyngeal cancer was reported in New Zealand and Queensland, Australia in the 1982–2010 period, while the incidence of oral cavity cancer remained unchanged or decreased in men in Queensland (<xref ref-type="bibr" rid="b50">50</xref>).</p>
         </sec>
         <sec id="s4.3" sec-type="Inconsistent reporting of oral cancer in Slovenia">
            <label>4.3</label>
            <title>Inconsistent reporting of oral cancer in Slovenia</title>
            <p>In Slovenia, oropharyngeal cancer is the main contributor to the burden of oral cancer as per our analysis. There are difficulties in accessing this area during clinical examination, and patients themselves do not notice or feel a change in the mucosa only when it is accompanied by more serious symptoms (pain, swelling, bleeding from the wound, difficulty in chewing and swallowing) (<xref ref-type="bibr" rid="b4">4</xref>).</p>
            <p>Oral cavity cancer is most commonly found (69 %) at the floor of mouth and tongue, as these two sites are most exposed to the main risk factors. Half of the cases of oral cavity cancer (N = 1.335) are defined as an “overlapping lesion” or “unspecified site”. This means that the cancer was discovered late, in its advanced stage, so the exact origin is more difficult to determine. Furthermore, the primary site is inaccurately described and is registered in the CRS with the category “unspecified site”. Unpublished results show that between 1994 and 1995 there was a sharp increase in the definitions of “overlapping lesion” and a decline in the definitions of “unspecified site”. This is due to a change in the recording of new cancer cases according to the ICD-10 classification, which succeeded the ICD-8, where “overlapping lesions” and “unspecified site” were a joint category. CRS, however, does not correct for previously entered data.</p>
            <p>Cancer reporting in Slovenia has been mandatory and statutory since CRS was established at the Institute of Oncology Ljubljana in 1950. All hospitals in the Republic of Slovenia, public health institutes, and other legal and natural persons performing healthcare services must provide the prescribed information on the Cancer Registration Form regularly. In addition to presenting the burden of cancer in the country, this data serve as the starting point for evaluating the success of oncology prevention, diagnosis, treatment, rehabilitation, palliative care, and the planning of cancer management capabilities and resources.</p>
            <p>The physician reporting the disease on the Cancer Registration Form fills in or identifies the primary site of cancer descriptively, but not by coding the ICD-10 category and subcategory. This information is transferred to the registry where the site is coded with the ICD-10 category and subcategory. Subcategory cancer coding is often difficult, as the site description on the application form is often lacking in information. Which ICD-10 category entered in the registry is the most appropriate for some vague description of a site, is determined by international and CRS-agreed rules. The registry spends a great deal of time searching for incompletely recorded or even incorrect information on the registration form (<xref ref-type="bibr" rid="b33">33</xref>,<xref ref-type="bibr" rid="b51">51</xref>).</p>
         </sec>
         <sec id="s4.4" sec-type="Recommendations for defining oral cancer">
            <label>4.4</label>
            <title>Recommendations for defining oral cancer</title>
            <p>The definition of oral cancer is not consistent in the literature either (<xref ref-type="bibr" rid="b52">52</xref>). Textbooks, professional articles, and websites of foreign associations (National Cancer Institute (<xref ref-type="bibr" rid="b53">53</xref>), American Joint Committee on Cancer (<xref ref-type="bibr" rid="b54">54</xref>), American Head &amp; Neck Society (<xref ref-type="bibr" rid="b55">55</xref>), American Cancer Society (<xref ref-type="bibr" rid="b56">56</xref>), Cancer Research UK (<xref ref-type="bibr" rid="b57">57</xref>)) lack clear definitions. We find different classifications. Most inconsistencies are found in the classification of lip, lingual tonsils, and soft palate cancers under oral cavity cancer.</p>
            <p>There are several reasons for the difficulties in defining oral cancer. From a clinical point of view, this pathology is managed by dentists, family medicine specialists, maxillofacial and oral surgeons, ENT specialists, etc. The anatomical area is very diverse and there are no clear transitions between structures. Embryologically, the lip, oral cavity, and pharynx are formed from the primary oral cavity (ectoderm) and foregut (endoderm), which are separated by the oropharyngeal membrane by the 8<sup>th</sup> embryonic week. Thus, the development of the lip, cheek, hard palate, and ventral surface of the tongue originates from the ectoderm, and the soft palate, pharynx, and dorsal surface of the tongue develop from the endoderm (<xref ref-type="bibr" rid="b58">58</xref>). In addition, there are numerous risk factors for oral cancer (<xref ref-type="bibr" rid="b3">3</xref>).</p>
            <p>For the definition of oral cancer (<xref ref-type="table" rid="table1">Table 1</xref>) we also used current articles in the field of defining oral cancer (<xref ref-type="bibr" rid="b2">2</xref>,<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b52">52</xref>) in addition to the international classifications mentioned under methods section of this article. Tapia and Goldberg (<xref ref-type="bibr" rid="b52">52</xref>) highlight the non-uniform classification of the definition of oral cancer and its site. Their findings were supported in the following years by Radöi and Luce (<xref ref-type="bibr" rid="b3">3</xref>) with a systematic review of 102 articles from different countries (all continents), which provided definitions of the oral cavity of individual authors. We upgraded the definitions referred to in their article (<xref ref-type="bibr" rid="b3">3</xref>) by a separate definition for the lip (vermilion border and lipstick area). This is significant because, in lip cancer, the risk factors and age of the patients at diagnosis are different from cases of oral cavity and oropharyngeal cancer (<xref ref-type="bibr" rid="b22">22</xref>). The lingual tonsil and soft palate were classified as part of the oropharynx. For the purpose of comparative studies, these three sites can be classified under the oral cavity. Categories C07 and C08 were excluded from the analysis, since most salivary gland cancers are not squamous cell carcinomas, and the etiological factors are different from the etiologic factors of oral cancer (<xref ref-type="bibr" rid="b59">59</xref>,<xref ref-type="bibr" rid="b60">60</xref>). The C11 category was also excluded from the analysis due to differences in etiological factors (<xref ref-type="bibr" rid="b61">61</xref>,<xref ref-type="bibr" rid="b62">62</xref>). Categories C12 and C13 were excluded from the analysis because of their anatomical location, which does not belong to the oral region. Category C14 was excluded from the analysis, although it includes malignant neoplasms of other and ill-defined sites in the lip, oral cavity and pharynx (pharynx, Waldeyer’s ring, overlapping lesions of lip, oral cavity and pharynx). Only 23 such cases have been identified in 30 years.</p>
         </sec>
         <sec id="s4.5"
              sec-type="Recommendations for the prevention and early detection of oral cancer">
            <label>4.5</label>
            <title>Recommendations for the prevention and early detection of oral cancer</title>
            <p>Dentists and physicians need to pay attention to any changes in the oral area, especially in the at-risk population, which is more likely to develop oral cancer. The most at risk are men over the age of 50, with lower socioeconomic status, excessive alcohol consumers and smokers. Due to changing trends in the incidence of oral cancer and the increasingly important role of HPV infection (<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref>), more attention should be paid to the younger population. Advice on safe sex and possible additional protection against HPV infection is recommended. HPV vaccination was introduced in Slovenia in 2009 and is voluntary. Free vaccination is available for girls aged 11–12 years, as the vaccine’s effectiveness is greatest if administered before first sexual activity. The vaccine is also available for boys and adult women (<xref ref-type="bibr" rid="b63">63</xref>). The efficacy of vaccination against HPV infection in both sexes in the prevention of oral cancer, in contrast to the effectiveness of vaccination in cancer prevention in the anogenital area, has not yet been demonstrated (<xref ref-type="bibr" rid="b64">64</xref>-<xref ref-type="bibr" rid="b68">68</xref>). Despite the introduction of the vaccination, the most important prevention against HPV infection, which could lead to the development of oral cancer, are safe sex and preventive dental/medical examinations.</p>
            <p>The ratio between the number of dentists and the population of Slovenia (1/1,370) allows each person to be examined by a dentist once a year. During the check-up the dentist inspects the entire oral area, whether or not the person reports any problems (<xref ref-type="bibr" rid="b69">69</xref>). People need to be empowered to take responsibility for taking care of their own oral health. We need to explain to them that we have no influence on some risk factors, such as gender and age, while other risk factors are variable (tobacco and alcohol use, unbalanced diet, poor oral hygiene, sun exposure, HPV infection, lower socioeconomic status). Regular visits to the dentist and self-examination of the oral area, which is recommended once a month, are crucial, regardless of the absence of any problems. The course of treatment for a patient with oral cancer from the onset of the first symptom to the diagnosis procedure is not well defined. In case of a visible change (changes in soft tissues, white or red spots or wounds that do not heal within two weeks), the person should visit the dentist immediately or is referred by the dentist (if necessary) to a specialist examination or is scheduled for follow-up examinations more often.</p>
            <p>As many as 80 % of patients with oral cancer are referred for treatment by dentists (<xref ref-type="bibr" rid="b69">69</xref>). Selected general physicians, family medicine specialists, also play an important role in detecting precancerous and cancerous lesions in the oral area, as they see their patients more often than their dentists. One part of the clinical examination during the visit with a family medicine specialist is a basic oral examination (<xref ref-type="bibr" rid="b70">70</xref>). The guidelines for patient management from diagnosis onwards are set out in detail and are freely available on the Institute of Oncology website (<xref ref-type="bibr" rid="b71">71</xref>).</p>
            <p>Continuing professional training for dentists and physicians is essential to the advancement of oral cancer knowledge. The acquired knowledge should be used to raise awareness of the importance of prevention and early detection of oral cancer among individuals and the public, as only this will establish the continuity of preventive action in this field. In addition to general advice for reducing the risk of cancer (<xref ref-type="bibr" rid="b72">72</xref>), we should also emphasize the promotion of oral health to help raise awareness of the importance of oral health for overall health and the risk factors for oral cancer.</p>
         </sec>
      </sec>
      <sec id="s5" sec-type="Conclusion">
         <label>5</label>
         <title>Conclusion</title>
         <p>Following a thorough review of the literature and other available data, the definition of the oral area has not been generally established in the Slovenian space. The analysis of the data also revealed that the identification of the exact primary cancer site on the Cancer Registration Form is incomplete, which may lead to inaccurate epidemiological cancer data. That is why we have presented the classification of oral cancer, which is suitable for the Slovenian space in terms of etiological factors and the clinical and epidemiological treatment of this cancer. For future epidemiological monitoring of the burden of oral cancer we recommend the described classification per site: the lip, oral cavity, and oropharynx.</p>
         <p>Oral cancer is one of the major public health, social, and economic problems of modern society. Our contribution wishes to highlight the problem of late detection of this cancer despite the accessibility of the oral area for a clinical examination. Early cancer detection contributes to improving the survival and quality of life of patients, and particular attention should be paid to the management of this disease.</p>
      </sec>
   </body>
   <back>
      <ack>
         <label>6</label>
         <title>Acknowledgements</title>
         <p>The authors wish to acknowledge the help provided by CRS, especially Katarina Lokar and Tina Žagar, for their participation in conducting the research and statistical data processing.</p>
      </ack>
      <ref-list>
         <ref id="b1">
            <label>1. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Warnakulasuriya</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Global epidemiology of oral and oropharyngeal cancer</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2009</year>
                    <month>Apr-May</month>;
                    <volume>45</volume>(
                    <issue>4-5</issue>):
                    <fpage>309</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2008.06.002</pub-id>
                    <pub-id pub-id-type="pmid">18804401</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b2">
            <label>2. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Montero</surname>
                     <given-names>PH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Patel</surname>
                     <given-names>SG</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Cancer of the oral cavity</article-title>. 
                    <source>Surg Oncol Clin N Am</source>. 
                    <year>2015</year>
                    <month>Jul</month>;
                    <volume>24</volume>(
                    <issue>3</issue>):
                    <fpage>491</fpage>–
                    <lpage>508</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.soc.2015.03.006</pub-id>
                    <pub-id pub-id-type="pmid">25979396</pub-id>
                    <issn>1055-3207</issn>
                </mixed-citation>
         </ref>
         <ref id="b3">
            <label>3. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Radoi</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Luce</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>A review of risk factors for oral cavity cancer: the importance of a standardized case definition</article-title>. 
                    <source>Community Dent Oral Epidemiol</source>. 
                    <year>2013</year>
                    <month>Apr</month>;
                    <volume>41</volume>(
                    <issue>2</issue>):
                    <fpage>97</fpage>–
                    <lpage>109</lpage>. 
                   <pub-id pub-id-type="doi">10.1111/j.1600-0528.2012.00710.x</pub-id>
                   <pub-id pub-id-type="pmid">22882534</pub-id>
                    <issn>0301-5661</issn>
                </mixed-citation>
         </ref>
         <ref id="b4">
            <label>4. </label>
            <mixed-citation publication-type="book">
                 <person-group person-group-type="editor">
                 <name name-style="western">
                     <surname>Benzian</surname>
                     <given-names>M</given-names>
                  </name>,
                   <name name-style="western">
                     <surname>Williams</surname>
                     <given-names>D</given-names>
                  </name> 
                   </person-group>.
                   <source>The Oral Health Atlas</source>.
                   <edition>2nd ed</edition>. 
                   <publisher-loc>Geneva</publisher-loc>:
                   <publisher-name>FDI World Dental Federation</publisher-name>;
                   <year>2015</year>. pp. 
                   <fpage>6</fpage>–
                   <lpage>69</lpage>.
                   (<series>The challenge of oral disease. A call for global action</series>).
                </mixed-citation>
         </ref>
         <ref id="b5">
            <label>5. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                    <collab>International Agency for Research on Cancer</collab> 
                    </person-group>. 
                    <source>WHO: International Agency for Research on Cancer. A digital manual for the early diagnosis of oral neoplasia. Squamous cell carcinoma</source>.
                    <year>2019</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-22">cited 2019 Mar 22</date-in-citation>]. 
                    <comment>Available from: <uri>https://screening.iarc.fr/atlasoral_list.php?cat=B2&amp;lang=1</uri>
               </comment>.
            </mixed-citation>
         </ref>
         <ref id="b6">
            <label>6. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Yete</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>D’Souza</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saranath</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>High-risk human papillomavirus in oral cancer: clinical implications</article-title>. 
                    <source>Oncology</source>. 
                    <year>2018</year>;
                    <volume>94</volume>(
                    <issue>3</issue>):
                    <fpage>133</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1159/000485322</pub-id>
                    <pub-id pub-id-type="pmid">29241220</pub-id>
                    <issn>0030-2414</issn>
                </mixed-citation>
         </ref>
         <ref id="b7">
            <label>7. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tay</surname>
                     <given-names>SK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Oon</surname>
                     <given-names>LL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study</article-title>. 
                    <source>Int J STD AIDS</source>. 
                    <year>2014</year>
                    <month>Dec</month>;
                    <volume>25</volume>(
                    <issue>14</issue>):
                    <fpage>1013</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/0956462414528315</pub-id>
                    <pub-id pub-id-type="pmid">24648316</pub-id>
                    <issn>0956-4624</issn>
                </mixed-citation>
         </ref>
         <ref id="b8">
            <label>8. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Shah</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Malik</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Garg</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mair</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Nair</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>P</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature</article-title>. 
                    <source>Postgrad Med J</source>. 
                    <year>2017</year>
                    <month>Nov</month>;
                    <volume>93</volume>(
                    <issue>1105</issue>):
                    <fpage>704</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1136/postgradmedj-2016-134603</pub-id>
                    <pub-id pub-id-type="pmid">28778951</pub-id>
                    <issn>0032-5473</issn>
                </mixed-citation>
         </ref>
         <ref id="b9">
            <label>9. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>WF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fakhry</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2015</year>
                    <month>Oct</month>;
                    <volume>33</volume>(
                    <issue>29</issue>):
                    <fpage>3235</fpage>–
                    <lpage>42</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2015.61.6995</pub-id>
                    <pub-id pub-id-type="pmid">26351338</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b10">
            <label>10. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Engels</surname>
                     <given-names>EA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>WF</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2008</year>
                    <month>Feb</month>;
                    <volume>26</volume>(
                    <issue>4</issue>):
                    <fpage>612</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2007.14.1713</pub-id>
                    <pub-id pub-id-type="pmid">18235120</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b11">
            <label>11. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Strojan</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Šifrer</surname>
                     <given-names>R</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lanišnik</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Didanović</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jereb</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection</article-title>. 
                    <source>Eur Arch Otorhinolaryngol</source>. 
                    <year>2015</year>
                    <month>Dec</month>;
                    <volume>272</volume>(
                    <issue>12</issue>):
                    <fpage>3805</fpage>–
                    <lpage>14</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00405-014-3459-7</pub-id>
                    <pub-id pub-id-type="pmid">25542247</pub-id>
                    <issn>0937-4477</issn>
                </mixed-citation>
         </ref>
         <ref id="b12">
            <label>12. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Deschler</surname>
                     <given-names>DG</given-names>
                  </name>, 
                       <name name-style="western">
                     <surname>Richmon</surname>
                     <given-names>JD</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Khariwala</surname>
                     <given-names>SS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferris</surname>
                     <given-names>RL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wang</surname>
                     <given-names>MB</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation</article-title>. 
                    <source>Otolaryngol Head Neck Surg</source>. 
                    <year>2014</year>
                    <month>Sep</month>;
                    <volume>151</volume>(
                    <issue>3</issue>):
                    <fpage>375</fpage>–
                    <lpage>80</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/0194599814538605</pub-id>
                    <pub-id pub-id-type="pmid">24925311</pub-id>
                    <issn>0194-5998</issn>
                </mixed-citation>
         </ref>
         <ref id="b13">
            <label>13. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Patel</surname>
                     <given-names>R</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The state of oral health in Europe</article-title>. 
                    <year iso-8601-date="2012">2012</year>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-22">cited 2019 March 22</date-in-citation>].
                    <comment>Available from:<uri>http://www.oralhealthplatform.eu/our-work/the-state-of-oral-health-in-europe/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b14">
            <label>14. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <chapter-title>Ustna votlina</chapter-title>. In: 
                    <person-group person-group-type="editor">
                    <name name-style="western">
                     <surname>Primic-Žakelj</surname>
                     <given-names>M</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Žagar</surname>
                     <given-names>T</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>B</given-names>
                  </name>
                        <role>eds</role>,
                    </person-group>.
                    <source>Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Onkološki inštitut Ljubljana</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>36</fpage>-
                    <lpage>43</lpage>. 
                </mixed-citation>
         </ref>
         <ref id="b15">
            <label>15. </label>
            <mixed-citation publication-type="book-chapter">
                 <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                 <chapter-title>Ustno žrelo </chapter-title>. In: 
                <person-group person-group-type="editor">
                    <name name-style="western">
                     <surname>Primic-Žakelj</surname>
                     <given-names>M</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zadnik</surname>
                     <given-names>V</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Žagar</surname>
                     <given-names>T</given-names>
                  </name>, 
                    <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>B</given-names>
                  </name>
                  <role>eds</role>
                </person-group>. 
                    <source>Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Onkološki inštitut Ljubljana</publisher-name>;
                    <year>2009</year>. pp.
                    <fpage>28</fpage>-
                    <lpage>35</lpage>. 
                </mixed-citation>
         </ref>
         <ref id="b16">
            <label>16. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lafaurie</surname>
                     <given-names>GI</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Perdomo</surname>
                     <given-names>SJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Buenahora</surname>
                     <given-names>MR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Amaya</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Díaz-Báez</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Human papilloma virus: an etiological and prognostic factor for oral cancer?</article-title>
                    <source>J Investig Clin Dent</source>. 
                    <year>2018</year>
                    <month>May</month>;
                    <volume>9</volume>(
                    <issue>2</issue>):
                    <fpage>e12313</fpage>. 
                    <pub-id pub-id-type="doi">10.1111/jicd.12313</pub-id>
                    <pub-id pub-id-type="pmid">29322686</pub-id>
                    <issn>2041-1618</issn>
                </mixed-citation>
         </ref>
         <ref id="b17">
            <label>17. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>O’Rorke</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ellison</surname>
                     <given-names>MV</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Murray</surname>
                     <given-names>LJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moran</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>James</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Anderson</surname>
                     <given-names>LA</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2012</year>
                    <month>Dec</month>;
                    <volume>48</volume>(
                    <issue>12</issue>):
                    <fpage>1191</fpage>–
                    <lpage>201</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2012.06.019</pub-id>
                    <pub-id pub-id-type="pmid">22841677</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b18">
            <label>18. </label>
            <mixed-citation publication-type="webpage">
              <person-group person-group-type="author">
                  <collab>slora.si</collab>
              </person-group>. 
              <source>Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32)</source>.
              <year>2018</year>.
               [<date-in-citation content-type="access-date" iso-8601-date="2018-03-16">cited 2018 Mar 16</date-in-citation>].
              <comment>Available from: <uri>http://www.slora.si/c/document_library/get_file?uuid=e320aca2-d106-4478-8f0e-125255c5792e&amp;groupId=11561</uri>
               </comment>. 
          </mixed-citation>
         </ref>
         <ref id="b19">
            <label>19. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Brierley</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Gospodarowicz</surname>
                     <given-names>MK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Witterkind</surname>
                     <given-names>Ch</given-names>
                  </name>
                        <role>eds</role>
                    </person-group>.
                    <source>TNM Classification of Malignant Tumors</source>.
                    <edition>Eighth edition</edition>. 
                    <publisher-loc>Oxford, UK, Hoboken, NY</publisher-loc>:
                    <publisher-name>John Wiley &amp; Sons</publisher-name>;
                    <year>2017</year>. 
                </mixed-citation>
         </ref>
         <ref id="b20">
            <label>20. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Corp</surname>
                     <given-names>IB</given-names>
                  </name>
                    </person-group>. 
                    <source>IBM SPSS Statistics for Windows, Version 24.0</source>. 
                    <publisher-loc>Armonk, NY</publisher-loc>:
                    <publisher-name>IBM Corp.</publisher-name>; 
                    <year>2016</year>.
                </mixed-citation>
         </ref>
         <ref id="b21">
            <label>21. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <collab>Joinpoint Regression Program</collab> 
                    </person-group>. 
                    <source>Statistical Methodology and Applications Branch, Surveillance Research Program</source>.
                    <publisher-loc>Bethesda, MD</publisher-loc>:
                    <publisher-name>National Cancer Institute</publisher-name>;
                    <year>2014</year>.
                </mixed-citation>
         </ref>
         <ref id="b22">
            <label>22. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Moore</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pierce</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wilson</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The epidemiology of lip cancer: a review of global incidence and aetiology</article-title>. 
                    <source>Oral Dis</source>. 
                    <year>1999</year>
                    <month>Jul</month>;
                    <volume>5</volume>(
                    <issue>3</issue>):
                    <fpage>185</fpage>–
                    <lpage>95</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1601-0825.1999.tb00300.x</pub-id>
                    <pub-id pub-id-type="pmid">10483063</pub-id>
                    <issn>1354-523X</issn>
                </mixed-citation>
         </ref>
         <ref id="b23">
            <label>23.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bota</surname>
                     <given-names>JP</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lyons</surname>
                     <given-names>AB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Carroll</surname>
                     <given-names>BT</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Squamous cell carcinoma of the lip–a review of squamous cell carcinogenesis of the mucosal and cutaneous junction</article-title>. 
                    <source>Dermatol Surg</source>. 
                    <year>2017</year>
                    <month>Apr</month>;
                    <volume>43</volume>(
                    <issue>4</issue>):
                    <fpage>494</fpage>–
                    <lpage>506</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/DSS.0000000000001020</pub-id>
                    <pub-id pub-id-type="pmid">28157733</pub-id>
                    <issn>1076-0512</issn>
                </mixed-citation>
         </ref>
         <ref id="b24">
            <label>24. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <collab>World Health Organization, International Agency for Research on Cancer</collab>.
                    </person-group>. 
                    <source>Human papillomaviruses</source>.
                    <publisher-loc>Lyon</publisher-loc>: 
                    <publisher-name>IARC</publisher-name>; 
                    <year>2007</year>. pp. 
                    <fpage>223</fpage>–
                    <lpage>76</lpage>.
                    <series>IARC monographs on the evaluation of carcinogenic risks to humans; vol. 90</series>.
                </mixed-citation>
         </ref>
         <ref id="b25">
            <label>25. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gillison</surname>
                     <given-names>ML</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Koch</surname>
                     <given-names>WM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Capone</surname>
                     <given-names>RB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Spafford</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Westra</surname>
                     <given-names>WH</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wu</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Evidence for a causal association between human papillomavirus and a subset of head and neck cancers</article-title>. 
                    <source>J Natl Cancer Inst</source>. 
                    <year>2000</year>
                    <month>May</month>;
                    <volume>92</volume>(
                    <issue>9</issue>):
                    <fpage>709</fpage>–
                    <lpage>20</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jnci/92.9.709</pub-id>
                    <pub-id pub-id-type="pmid">10793107</pub-id>
                    <issn>0027-8874</issn>
                </mixed-citation>
         </ref>
         <ref id="b26">
            <label>26. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Chaturvedi</surname>
                     <given-names>AK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Engels</surname>
                     <given-names>EA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pfeiffer</surname>
                     <given-names>RM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hernandez</surname>
                     <given-names>BY</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Xiao</surname>
                     <given-names>W</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kim</surname>
                     <given-names>E</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Human papillomavirus and rising oropharyngeal cancer incidence in the United States</article-title>. 
                    <source>J Clin Oncol</source>. 
                    <year>2011</year>
                    <month>Nov</month>;
                    <volume>29</volume>(
                    <issue>32</issue>):
                    <fpage>4294</fpage>–
                    <lpage>301</lpage>. 
                    <pub-id pub-id-type="doi">10.1200/JCO.2011.36.4596</pub-id>
                    <pub-id pub-id-type="pmid">21969503</pub-id>
                    <issn>0732-183X</issn>
                </mixed-citation>
         </ref>
         <ref id="b27">
            <label>27. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Diz</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Meleti</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Diniz-Freitas</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vescovi</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Warnakulasuriya</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Johnson</surname>
                     <given-names>NW</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Oral and pharyngeal cancer in Europe</article-title>. 
                    <source>Transl Res Oral Oncol</source>. 
                    <year>2017</year>;
                    <volume>2</volume>:
                    <fpage>1</fpage>–
                    <lpage>13</lpage>.
                    <issn>2057-178X</issn>
                </mixed-citation>
         </ref>
         <ref id="b28">
            <label>28. </label>
            <mixed-citation publication-type="webpage">
                <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <source>WHO | Metrics: Population Attributable Fraction (PAF)</source>.
                <comment>Available from:<uri>https://www.who.int/healthinfo/global_burden_disease/metrics_paf/en/</uri>
               </comment>.
          </mixed-citation>
         </ref>
         <ref id="b29">
            <label>29. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Plummer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>de Martel</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vignat</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferlay</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Bray</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Franceschi</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Global burden of cancers attributable to infections in 2012: a synthetic analysis</article-title>. 
                    <source>Lancet Glob Health</source>. 
                    <year>2016</year>
                    <month>Sep</month>;
                    <volume>4</volume>(
                    <issue>9</issue>):
                    <fpage>e609</fpage>–
                    <lpage>16</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S2214-109X(16)30143-7</pub-id>
                    <pub-id pub-id-type="pmid">27470177</pub-id>
                    <issn>2214-109X</issn>
                </mixed-citation>
         </ref>
         <ref id="b30">
            <label>30.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>de Martel</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Plummer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vignat</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Franceschi</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Worldwide burden of cancer attributable to HPV by site, country and HPV type</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2017</year>
                    <month>Aug</month>;
                    <volume>141</volume>(
                    <issue>4</issue>):
                    <fpage>664</fpage>–
                    <lpage>70</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.30716</pub-id>
                    <pub-id pub-id-type="pmid">28369882</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b31">
            <label>31. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Haeggblom</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ramqvist</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tommasino</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Dalianis</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Näsman</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years</article-title>. 
                    <source>Papillomavirus Res</source>. 
                    <year>2017</year>
                    <month>Dec</month>;
                    <volume>4</volume>:
                    <fpage>1</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.pvr.2017.05.002</pub-id>
                    <pub-id pub-id-type="pmid">29179862</pub-id>
                    <issn>2405-8521</issn> 
                </mixed-citation>
         </ref>
         <ref id="b32">
            <label>32. </label>
            <mixed-citation publication-type="webpage">
                 <person-group person-group-type="author">
                     <collab>Public Health England. National Cancer Registration and Analysis Service, NCRAS</collab>. 
                 </person-group>.
                 <source>The importance of skin cancer registration – NCIN data briefing</source>. 
                 <comment>Available from:<uri>http://www.ncin.org.uk/publications/data_briefings/skin_cancer_registration</uri>
               </comment>.
            </mixed-citation>
         </ref>
         <ref id="b33">
            <label>33. </label>
            <mixed-citation publication-type="book">
                <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <source>Rak v Sloveniji 2017</source>. 
                <publisher-loc>Ljubljana</publisher-loc>:
                <publisher-name>Onkološki inštitut Ljubljana, Epidemiologija in register raka, Register Raka Republike Slovenije</publisher-name>;
                <year>2017</year>. pp.
                <fpage>9</fpage>-
                <lpage>11</lpage>.
            </mixed-citation>
         </ref>
         <ref id="b34">
            <label>34. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Anselmo Lima</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sampaio Lima</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Maria Da Silva</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Prado Nunes</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Macedo Lima</surname>
                     <given-names>MM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Oliveira Santos</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?</article-title>
                    <source>Eur J Dermatol</source>. 
                    <year>2018</year>
                    <month>Apr</month>;
                    <volume>28</volume>(
                    <issue>2</issue>):
                    <fpage>169</fpage>–
                    <lpage>76</lpage>. 
                    <pub-id pub-id-type="doi">10.1684/ejd.2018.3248</pub-id>
                    <pub-id pub-id-type="pmid">29619990</pub-id>
                    <issn>1167-1122</issn>
                </mixed-citation>
         </ref>
         <ref id="b35">
            <label>35. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32)</source>.
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-03-16">cited 2018 Mar 16</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.slora.si/c/document_library/get_file?uuid=e320aca2-d106-4478-8f0e-125255c5792e&amp;groupId=11561</uri>
               </comment>.
            </mixed-citation>
         </ref>
         <ref id="b36">
            <label>36. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Nacionalni inštitut za varno zdravje</collab>.
                    </person-group>. 
                    <source>Slovenija. Varno s soncem v vrtcih</source>.
                    <year>2019</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-22">cited 2019 Mar 22</date-in-citation>]. 
                <comment>Available from:<uri>http://www.nijz.si/sl/program-varno-s-soncem-v-vrtcih</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b37">
            <label>37. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                            <collab>Nacionalni inštitut za varno zdravje</collab>.
                    </person-group>. 
                    <article-title>Slovenija. Varno s soncem v osnovnih šolah</article-title>. 
                    <year>2019</year> 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-22">cited 2019 Mar 22</date-in-citation>]. 
                <comment>Available from:<uri>http://www.nijz.si/sl/program-varno-s-soncem-v-osnovnih-solah</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b38">
            <label>38. </label>
            <mixed-citation publication-type="journal">
               <person-group>
                  <collab/>
               </person-group>
               <article-title>Zakon o omejevanju uporabe tobačnih izdelkov</article-title>.
              <source>Ur l RS</source>. 
              <year>1996</year>;( 
              <issue>57</issue>),
              <year>2002</year>.( 
              <issue>119</issue>),
              <year>2005</year>.( 
              <issue>101</issue>),
              <year>2007</year>.( 
              <issue>60</issue>).
            </mixed-citation>
         </ref>
         <ref id="b39">
            <label>39. </label>
            <mixed-citation publication-type="journal">
                    <article-title>Zakon o omejevanju porabe alkohola – ZOPA</article-title>. 
                    <source>Ur l RS</source>. 
                    <year>2003</year>.( 
                    <issue>15</issue>).
                </mixed-citation>
         </ref>
         <ref id="b40">
            <label>40. </label>
            <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Toš</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Klinar</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Markič</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Roter</surname>
                     <given-names>Z</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vreg</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Trampuž</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <source>Slovenian Public Opinion survey 1978</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Faculty of Social Sciences University of Ljubljana and Public Opinion and Mass Communication Research Centre</publisher-name>; 
                    <year>1978</year>.
                </mixed-citation>
         </ref>
         <ref id="b41">
            <label>41. </label>
            <mixed-citation publication-type="book-chapter">
              <person-group person-group-type="author">
                 <name name-style="western">
                     <surname>Koprivnikar</surname>
                     <given-names>H</given-names>
                  </name>
              </person-group>. 
              <chapter-title>Tobak</chapter-title>. In:
              <person-group person-group-type="editor">
                  <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zaletel-Kragelj</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>:  z
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2012</year>. pp.
                    <fpage>71</fpage>- 
                    <lpage>88</lpage>. 
                </mixed-citation>
         </ref>
         <ref id="b42">
            <label>42. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>B</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Alkohol</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Zakotnik</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>I</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zaletel-Kragelj</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2012</year>. pp.
                    <fpage>89</fpage>- 
                    <lpage>107</lpage>. 
                </mixed-citation>
         </ref>
         <ref id="b43">
            <label>43. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lovrečič</surname>
                     <given-names>B</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Pitje alkohola</chapter-title>. In:
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Vinko</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kofol Bric</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Korošec</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tomšič</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Vrdelja</surname>
                     <given-names>M</given-names>
                  </name> 
                        <role>eds</role>.
                    </person-group>. 
                    <source>Kako skrbimo za zdravje? Z zdravjem povezan vedenjski slog prebivalcev Slovenije 2016</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Inštitut za varovanje zdravja Republike Slovenije</publisher-name>; 
                    <year>2018</year>. pp.
                    <fpage>17</fpage>- 
                    <lpage>20</lpage>. 
                </mixed-citation>
         </ref>
         <ref id="b44">
            <label>44. </label>
            <mixed-citation publication-type="book">
                <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                <source>WHO | Global information system on alcohol and health</source>. 
                <comment>Available from:<uri>https://www.who.int/gho/alcohol/en/</uri>
               </comment>. 
                </mixed-citation>
         </ref>
         <ref id="b45">
            <label>45. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Bravi</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Edefonti</surname>
                     <given-names>V</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Randi</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ferraroni</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>La Vecchia</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Decarli</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Dietary patterns and upper aerodigestive tract cancers: an overview and review</article-title>. 
                    <source>Ann Oncol</source>. 
                    <year>2012</year>
                    <month>Dec</month>;
                    <volume>23</volume>(
                    <issue>12</issue>):
                    <fpage>3024</fpage>–
                    <lpage>39</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/annonc/mds197</pub-id>
                    <pub-id pub-id-type="pmid">22967993</pub-id>
                    <issn>0923-7534</issn>
                </mixed-citation>
         </ref>
         <ref id="b46">
            <label>46. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Olaleye</surname>
                     <given-names>O</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ekrikpo</surname>
                     <given-names>U</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lyne</surname>
                     <given-names>O</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wiseberg</surname>
                     <given-names>J</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Incidence and survival trends of lip, intra-oral cavity and tongue base cancers in south-east England</article-title>. 
                    <source>Ann R Coll Surg Engl</source>. 
                    <year>2015</year>
                    <month>Apr</month>;
                    <volume>97</volume>(
                    <issue>3</issue>):
                    <fpage>229</fpage>–
                    <lpage>34</lpage>. 
                    <pub-id pub-id-type="doi">10.1308/003588414X14055925061676</pub-id>
                    <pub-id pub-id-type="pmid">26263810</pub-id>
                    <issn>0035-8843</issn>
                </mixed-citation>
         </ref>
         <ref id="b47">
            <label>47.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>van Dijk</surname>
                     <given-names>BA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Brands</surname>
                     <given-names>MT</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Geurts</surname>
                     <given-names>SM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Merkx</surname>
                     <given-names>MA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Roodenburg</surname>
                     <given-names>JL</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>139</volume>(
                    <issue>3</issue>):
                    <fpage>574</fpage>–
                    <lpage>83</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.30107</pub-id>
                    <pub-id pub-id-type="pmid">27038013</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b48">
            <label>48. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Johansen</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Grau Eriksen</surname>
                     <given-names>J</given-names>
                  </name>; 
                        <collab>Academy of Geriatric Cancer Research (AgeCare)</collab>
                    </person-group>. 
                    <article-title>Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012</article-title>. 
                    <source>Acta Oncol</source>. 
                    <year>2016</year>;
                    <volume>55</volume>(
                    <issue>sup1</issue>
                    <supplement>Suppl 1</supplement>):
                    <fpage>13</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/0284186X.2015.1114672</pub-id>
                    <pub-id pub-id-type="pmid">26760291</pub-id>
                    <issn>0284-186X</issn>
                </mixed-citation>
         </ref>
         <ref id="b49">
            <label>49. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kingsley</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>O’Malley</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ditmyer</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chino</surname>
                     <given-names>M</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Analysis of oral cancer epidemiology in the US reveals state-specific trends: Implications for oral cancer prevention</article-title>. 
                    <source>BMC Public Health</source>. 
                    <year>2018</year>;
                    <volume>8</volume>: 
                    <fpage>87</fpage>.
                    <pub-id pub-id-type="doi">10.1186/1471-2458-8-87</pub-id>
                    <pub-id pub-id-type="pmid">18331638</pub-id>
                    <issn>1471-2458</issn> 
                </mixed-citation>
         </ref>
         <ref id="b50">
            <label>50. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Elwood</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Youlden</surname>
                     <given-names>DR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Chelimo</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Ioannides</surname>
                     <given-names>SJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Baade</surname>
                     <given-names>PD</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia</article-title>. 
                    <source>Cancer Epidemiol</source>. 
                    <year>2014</year>
                    <month>Feb</month>;
                    <volume>38</volume>(
                    <issue>1</issue>):
                    <fpage>16</fpage>–
                    <lpage>21</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.canep.2013.12.004</pub-id>
                    <pub-id pub-id-type="pmid">24445141</pub-id>
                    <issn>1877-7821</issn>
                </mixed-citation>
         </ref>
         <ref id="b51">
            <label>51. </label>
            <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Onkološki inštitut=Institut of Oncology Ljubljana</collab>
                    </person-group>. 
                    <article-title>Register raka Republike Slovenije in drugi registri</article-title>. 
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="218-06-03">cited 2018 Jun 3</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.onko-i.si/rrs/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b52">
            <label>52. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tapia</surname>
                     <given-names>JL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goldberg</surname>
                     <given-names>LJ</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The challenges of defining oral cancer: analysis of an ontological approach</article-title>. 
                    <source>Head Neck Pathol</source>. 
                    <year>2011</year>
                    <month>Dec</month>;
                    <volume>5</volume>(
                    <issue>4</issue>):
                    <fpage>376</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s12105-011-0300-0</pub-id>
                    <pub-id pub-id-type="pmid">21915705</pub-id>
                    <issn>1936-055X</issn>
                </mixed-citation>
         </ref>
         <ref id="b53">
            <label>53. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Head and neck cancers. What are cancers of the head and neck?</source>
                    <year>2017</year>.
                    <comment>Available from:<uri>https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b54">
            <label>54. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Amin</surname>
                     <given-names>MB</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Edge</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Greene</surname>
                     <given-names>F</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Byrd</surname>
                     <given-names>DR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Brookland</surname>
                     <given-names>RK</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>Washington</surname>
                     <given-names>MK</given-names>
                  </name>, 
                        <etal>et al</etal>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>AJCC Cancer Staging Manual</source>.
                    <edition>8th ed</edition>.
                    <publisher-loc>Chicago</publisher-loc>: 
                    <publisher-name>Springer</publisher-name>; 
                    <year>2017</year>. 
                </mixed-citation>
         </ref>
         <ref id="b55">
            <label>55. </label>
            <mixed-citation publication-type="book">
               <person-group person-group-type="editor">
                  <name name-style="western">
                     <surname>Lui</surname>
                     <given-names>JC</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Pagedar</surname>
                     <given-names>NA</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Goldenberg</surname>
                     <given-names>D</given-names>
                  </name>, 
                  <name name-style="western">
                     <surname>Gross</surname>
                     <given-names>ND</given-names>
                  </name>, 
                  <role>eds</role>
               </person-group>
              <source>Oral cavity cancer</source>. 
              <publisher-loc>Los Angeles, CA</publisher-loc>: 
               <publisher-name>American Head and Neck Society</publisher-name>; 
              <year>2017</year>.
             </mixed-citation>
         </ref>
         <ref id="b56">
            <label>56. </label>
            <mixed-citation publication-type="webpage">
               <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Oral cavity and oropharyngeal cancer. What are oral cavity and oropharyngeal cancers?</source>
                    <comment>Available from:<uri>https://www.cancer.org/content/dam/CRC/PDF/Public/8763.00.pdf</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b57">
            <label>57. </label>
            <mixed-citation publication-type="webpage">
                   <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Mouth and oropharyngeal cancer. About mouth and oropharyngeal cancer</source>. 
                    <comment>Available from:<uri>https://www.cancerresearchuk.org/about-cancer/mouth-cancer/about</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b58">
            <label>58. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Gašperšič</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Košir</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Jevnikar</surname>
                     <given-names>N</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Razvoj obraza in ustne votline</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Gašperšič</surname>
                     <given-names>C</given-names>
                  </name>
                        <role>ed</role>
                    </person-group>. 
                    <source>Razvoj obraza, ustne votline in zobnega organa</source>. 
                        <edition>2nd ed</edition>. 
                        <publisher-loc>Ljubljana</publisher-loc>: 
                        <publisher-name>Medicinska fakulteta</publisher-name>; 
                        <year>2002</year>. pp. 
                        <fpage>7</fpage>- 
                        <fpage>25</fpage>. 
                </mixed-citation>
         </ref>
         <ref id="b59">
            <label>59. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Trotta</surname>
                     <given-names>BM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pease</surname>
                     <given-names>CS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Rasamny</surname>
                     <given-names>JJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Raghavan</surname>
                     <given-names>P</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mukherjee</surname>
                     <given-names>S</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning</article-title>. 
                    <source>Radiographics</source>. 
                    <year>2011</year>
                    <month>Mar-Apr</month>;
                    <volume>31</volume>(
                    <issue>2</issue>):
                    <fpage>339</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1148/rg.312105107</pub-id>
                    <pub-id pub-id-type="pmid">21415183</pub-id>
                    <issn>0271-5333</issn>
                </mixed-citation>
         </ref>
         <ref id="b60">
            <label>60. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>What Are the Risk Factors and Potential Causes for Salivary Gland Cancer?</source>
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date">cited 2018 Jun 3</date-in-citation>]. 
                <comment>Available from:<uri>https://www.cancer.org/cancer/salivary-gland-cancer/causes-risks-prevention/risk-factors.html</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b61">
            <label>61. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Tsao</surname>
                     <given-names>SW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Yip</surname>
                     <given-names>YL</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Tsang</surname>
                     <given-names>CM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Pang</surname>
                     <given-names>PS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lau</surname>
                     <given-names>VM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zhang</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Etiological factors of nasopharyngeal carcinoma</article-title>. 
                    <source>Oral Oncol</source>. 
                    <year>2014</year>
                    <month>May</month>;
                    <volume>50</volume>(
                    <issue>5</issue>):
                    <fpage>330</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.oraloncology.2014.02.006</pub-id>
                    <pub-id pub-id-type="pmid">24630258</pub-id>
                    <issn>1368-8375</issn>
                </mixed-citation>
         </ref>
         <ref id="b62">
            <label>62. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Zeng</surname>
                     <given-names>MS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Zeng</surname>
                     <given-names>YX</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Pathogenesis and etiology of nasopharyngeal carcinoma</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Lu</surname>
                     <given-names>JJ</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Cooper</surname>
                     <given-names>JS</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lee</surname>
                     <given-names>AW</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Nasopharyngeal Cancer: Multidisciplinary Management</source>.
                    <publisher-loc>Berlin</publisher-loc>:
                    <publisher-name>Springer Science &amp; Business Media</publisher-name>; 
                    <year>2010</year>. pp. 
                    <fpage>9</fpage>–
                    <lpage>25</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/978-3-540-92810-2_2</pub-id> 
                </mixed-citation>
         </ref>
         <ref id="b63">
            <label>63. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Zora. Državni program zgodnjega odkrivanja predrakavih sprememb materničnega vratu</source>. 
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-07">cited 2019 Mar 7</date-in-citation>]. 
                    <comment>Available from: <uri>https://zora.onko-i.si/za-zenske/preprecevanje-rmv/</uri>
               </comment>.
                </mixed-citation>
         </ref>
         <ref id="b64">
            <label>64. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Munoz</surname>
                     <given-names>N</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Kjaer</surname>
                     <given-names>SK</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sigurdsson</surname>
                     <given-names>K</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Iversen</surname>
                     <given-names>OE</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Hernandez-Avila</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Wheeler</surname>
                     <given-names>CM</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women</article-title>. 
                    <source>J Natl Cancer Inst</source>. 
                    <year>2010</year>
                    <month>Mar</month>;
                    <volume>102</volume>(
                    <issue>5</issue>):
                    <fpage>325</fpage>–
                    <lpage>39</lpage>. 
                    <pub-id pub-id-type="doi">10.1093/jnci/djp534</pub-id>
                    <pub-id pub-id-type="pmid">20139221</pub-id>
                    <issn>0027-8874</issn>
                </mixed-citation>
         </ref>
         <ref id="b65">
            <label>65. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Giuliano</surname>
                     <given-names>AR</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Palefsky</surname>
                     <given-names>JM</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Goldstone</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Moreira</surname>
                     <given-names>ED</given-names>
                     <suffix>Jr</suffix>
                  </name>, 
                        <name name-style="western">
                     <surname>Penny</surname>
                     <given-names>ME</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Aranda</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2011</year>
                    <month>Feb</month>;
                    <volume>364</volume>(
                    <issue>5</issue>):
                    <fpage>401</fpage>–
                    <lpage>11</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa0909537</pub-id>
                    <pub-id pub-id-type="pmid">21288094</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
         </ref>
         <ref id="b66">
            <label>66.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Guo</surname>
                     <given-names>T</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Eisele</surname>
                     <given-names>DW</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Fakhry</surname>
                     <given-names>C</given-names>
                  </name>
                    </person-group>. 
                    <article-title>The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer</article-title>. 
                    <source>Cancer</source>. 
                    <year>2016</year>
                    <month>Aug</month>;
                    <volume>122</volume>(
                    <issue>15</issue>):
                    <fpage>2313</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/cncr.29992</pub-id>
                    <pub-id pub-id-type="pmid">27152637</pub-id>
                    <issn>0008-543X</issn>
                </mixed-citation>
         </ref>
         <ref id="b67">
            <label>67. </label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Arbyn</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>de Sanjosé</surname>
                     <given-names>S</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Saraiya</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Sideri</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Palefsky</surname>
                     <given-names>J</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Lacey</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease</article-title>. 
                    <source>Int J Cancer</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>131</volume>(
                    <issue>9</issue>):
                    <fpage>1969</fpage>–
                    <lpage>82</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ijc.27650</pub-id>
                    <pub-id pub-id-type="pmid">22623137</pub-id>
                    <issn>0020-7136</issn>
                </mixed-citation>
         </ref>
         <ref id="b68">
            <label>68.	</label>
            <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Cobos</surname>
                     <given-names>C</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Figueroa</surname>
                     <given-names>JA</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Mirandola</surname>
                     <given-names>L</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Colombo</surname>
                     <given-names>M</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Summers</surname>
                     <given-names>G</given-names>
                  </name>, 
                        <name name-style="western">
                     <surname>Figueroa</surname>
                     <given-names>A</given-names>
                  </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review</article-title>. 
                    <source>Int Rev Immunol</source>. 
                    <year>2014</year>
                    <month>Oct</month>;
                    <volume>33</volume>(
                    <issue>5</issue>):
                    <fpage>383</fpage>–
                    <lpage>401</lpage>. 
                    <pub-id pub-id-type="doi">10.3109/08830185.2014.911857</pub-id>
                    <pub-id pub-id-type="pmid">24811210</pub-id>
                    <issn>0883-0185</issn>
                </mixed-citation>
         </ref>
         <ref id="b69">
            <label>69. </label>
            <mixed-citation publication-type="conference">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Terlević Dabić</surname>
                     <given-names>D</given-names>
                  </name>
                    </person-group>. 
                    <article-title>Vloga zobozdravnika – preventiva in zgodnje odkrivanje raka ustne votline</article-title>. In: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Kansky</surname>
                     <given-names>A</given-names>
                  </name>,
                        <name name-style="western">
                     <surname>Terlević Dabić</surname>
                     <given-names>D</given-names>
                  </name>, 
                        <role>eds</role>
                    </person-group>. 
                    <source>Zobozdravnik vidi bolje. Zato lahko reši življenje : zbornik predavanj</source>;
                    <conf-date>2017 Mar 18</conf-date>;
                    <conf-loc>Ljubljana, Slovenia</conf-loc>. 
                    <publisher-loc>Ljubljana</publisher-loc>:
                    <publisher-name>Zdravniška zbornica Slovenije</publisher-name>;  
                    <year>2017</year>. pp. 
                    <fpage>6</fpage>- 
                    <fpage>10</fpage>. 
                </mixed-citation>
         </ref>
         <ref id="b70">
            <label>70. </label>
            <mixed-citation publication-type="book-chapter">
                    <person-group person-group-type="author">
                        <name name-style="western">
                     <surname>Kocjančič</surname>
                     <given-names>A</given-names>
                  </name>
                    </person-group>. 
                    <chapter-title>Telesna preiskava</chapter-title>. In: 
                    <person-group person-group-type="editor">
                        <name name-style="western">
                     <surname>Kocijančič</surname>
                     <given-names>A</given-names>
                  </name> 
                        <role>ed</role>
                    </person-group>. 
                    <source>Klinična preiskava</source>. 
                    <publisher-loc>Ljubljana</publisher-loc>: 
                    <publisher-name>Littera picta</publisher-name>; 
                    <year>2017</year>. pp. 
                    <fpage>10</fpage>.
                </mixed-citation>
         </ref>
         <ref id="b71">
            <label>71. </label>
            <mixed-citation publication-type="webpage">
               <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>Smernice za zdravljenje tumorjev glave in vratu</source>.
                    <year>2018</year>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-06-03">cited 2018 Jun 3</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.onko-i.si/fileadmin/_migrated/content_uploads/Smernice_za_obravnavo_rakov_glave_in_vratu_01.pdf</uri>
               </comment>. 
            </mixed-citation>
         </ref>
         <ref id="b72">
            <label>72. </label>
            <mixed-citation publication-type="webpage">
                    <person-group>
                  <name name-style="western">
                     <surname/>
                  </name>
               </person-group>.
                    <source>WHO | Evropski kodeks proti raku</source>. 
                    <year>2019</year> 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-08">cited 2019 Mar 8</date-in-citation>]. 
                    <comment>Available from:<uri>https://cancer-code-europe.iarc.fr/index.php/sl/</uri>
               </comment>.
                </mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
